Turkish oncologists manage follow-up through hybrid care models combining remote digital monitoring with scheduled clinical visits. They establish protocols for molecular testing and toxicity tracking. Local teams coordinate with home-country doctors to integrate reports and imaging results. Bookimed manages all logistics and scheduling for these transitions.
- Molecular monitoring: Doctors schedule liquid biopsies or PET-CT scans to track tumor response and resistance.
- Toxicity management: Specialists provide strict timelines for home-country blood tests to monitor liver and renal function.
- Remote consultations: Patients access video appointments starting from $100 to review lab data and adjust dosages.
- Documentation hand-off: International departments generate exhaustive English medical reports and mutation panels for local oncologists.
Bookimed Expert Insight: Leading oncology centers in Turkey often integrate research-level precision into follow-up care. For example, Dr. Eda Tanrikulu at Anadolu Medical Center has led international clinical studies, while Dr. Nail Paksoy at Medipol focuses specifically on next-generation ALK inhibitors. This expertise means follow-up plans are not just about checking stats, but anticipating exactly when a specific targeted agent might need switching based on published real-world outcomes.
Patient Consensus: Patients note the importance of securing a clear next steps document before leaving Istanbul. They emphasize that while WhatsApp and email help, having every imaging CD and English pathology report is vital for their home doctors. Most feel relieved when a concrete schedule for blood work and symptom triggers is clearly written out.